IL11 and pemphigus foliaceus: Recently, interleukin 11 (IL‐11) was identified as a therapeutic target for PF because it contributes to fibroblast proliferation and promotes fibrosis,47 and was shown to be critical in the development of HPSPF in pluripotent cell‐derived organoids.48